Nephros, Inc. – Nephros, Inc. Up to 5,000,000 Shares of Common Stock Issuable Upon Exercise of Non-Transferable Rights to Subscribe for Such Shares the Subscription Rights Are Exercisable Until 5:00 p.m., Eastern Time, on May 17, 2013 Subject to Extension. (April 8th, 2013)
We are sending this letter to you because we hold shares of NEPHROS, INC. (the "Company") common stock, par value $0.001 per share (the "Common Stock") and/or Company warrants (the "Warrants") for you. The Company has commenced a rights offering of up to an aggregate of 5,000,000 shares of Common Stock of the Company (the "Shares") at a subscription price of $0.60 per Share (the "Subscription Price"), for up to an aggregate purchase price of $3,000,000, pursuant to the exercise of non-transferable subscription rights (the "Subscription Rights") distributed to all holders of record of shares of the Common Stock and the Warrants as of April 4, 2013 (the "Record Holders"). The Subscription Rights are described in the Company's prospectus, dated April [*], 2013 (the "Prospectus"), and evidenced by a subscription certificate (the "Subscription Certificate") registered in your name or in the name of your nominee.
Nephros, Inc. – Subscription Agent Agreement (April 8th, 2013)
THIS SUBSCRIPTION AGENT AGREEMENT ("Agreement") between Nephros, Inc., a Delaware corporation (the "Company"), and Continental Stock Transfer & Trust Company, a New York corporation ("Continental"), is dated as of [*], 2013.
Nephros, Inc. – Certificate No._____ No. Of Rights _____ (April 8th, 2013)
THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY'S PROSPECTUS DATED APRIL [*], 2013 (THE "PROSPECTUS") AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS ARE AVAILABLE UPON REQUEST FROM CONTINENTAL STOCK TRANSFER & TRUST COMPANY, THE SUBSCRIPTION AGENT.
Nephros, Inc. – License and Supply Agreement (April 26th, 2012)
This LICENSE and SUPPLY AGREEMENT (this "Agreement") is entered into as of April 23, 2012 (the "Effective Date") by and between Nephros, Inc., a Delaware corporation with its principal office at 41 Grand Ave, River Edge, NJ 07661, represented by its Chief Financial Officer Gerald J. Kochanski ("Nephros"), and Medica S.p.A., with registered office in Medolla (MO), Via Degli Artigiani, 7 - 41036, represented by its CEO Luciano Fecondini ("Medica"), and sometimes herein referred to individually as a "Party" and collectively, as the "Parties".
Nephros, Inc. – Employment Agreement (March 31st, 2011)
This EMPLOYMENT AGREEMENT (this "Agreement"), made in River Edge New Jersey as of the 1st day of April 2011 (the "Effective Date"), between Nephros, Inc., a Delaware corporation having its executive offices and principal place of business at 41 Grand Avenue, River Edge, NJ 07661 (the "Company"), and Gerald J. Kochanski ("Executive").
Nephros, Inc. – Separation, Release and Consulting Agreement (March 30th, 2010)
This SEPARATION, RELEASE AND CONSULTING AGREEMENT (the "Agreement") is made and entered into this 30th day of March 2010 by and between Ernest A. Elgin III (hereinafter "Executive") and Nephros, Inc., a Delaware corporation (the "Company").
Nephros, Inc. – Employment Agreement (May 15th, 2008)
As used herein, the "Maximum Severence Period" shall mean three months, until Executive has been employed hereunder for at least one year, and, thereafter, shall mean six months.